• Thu, March 3, 2016
  • Fri, March 4, 2016
  • Wed, March 9, 2016
  • Tue, March 8, 2016
  • Mon, March 7, 2016

Kennen MacKay Maintained (BMRN) at Buy with Increased Target to $114 on, Mar 3rd, 2016

Kennen MacKay of Credit Suisse, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $110 to $114 on, Mar 3rd, 2016.

Kennen has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Kennen's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Kennen


  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $105 on, Friday, February 26th, 2016
  • Joseph Schwartz of "Leerink Swann" Maintained at Buy with Decreased Target to $120 on, Tuesday, February 23rd, 2016